^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

CLL-1, CD33 and/or CD123-specific CAR gene-engineered T cells

i
Other names: CLL-1, CD33 and/or CD123-specific CAR gene-engineered T cells
Associations
News
Company:
SZGIMI
Drug class:
CD123-targeted CAR-T immunotherapy, CD33-targeted CAR-T immunotherapy, CLL-1-targeted CAR-T immunotherapy
Related drugs:
Associations
News